PREVYMIS

This brand name is authorized in Austria, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug PREVYMIS contains one active pharmaceutical ingredient (API):

1 Letermovir UNII 1H09Y5WO1F - LETERMOVIR

Letermovir inhibits the CMV DNA terminase complex which is required for cleavage and packaging of viral progeny DNA. Letermovir affects the formation of proper unit length genomes and interferes with virion maturation. Letermovir is indicated for prophylaxis of cytomegalovirus (CMV) reactivation and disease. Read about Letermovir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PREVYMIS Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AX18		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02469367, 02469375, 02469383, 02469405
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 7116-MEE-0322, 7118-MEE-0322
Country: EE	Ravimiamet	Identifier(s): 1762523, 1762534, 1762545, 1762556
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171245001, 1171245002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 196318, 529781
Country: FR	Base de données publique des médicaments	Identifier(s): 62944394, 64591854, 67334530, 67601314
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 365798, 388859
Country: HK	Department of Health Drug Office	Identifier(s): 66122, 66123, 66124, 66125
Country: IE	Health Products Regulatory Authority	Identifier(s): 89063, 89064
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8529, 8530
Country: IT	Agenzia del Farmaco	Identifier(s): 045890011, 045890023, 045890035, 045890047
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250048F1027, 6250406A1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1084801, 1084802, 1084803, 1084804
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 196525, 196533, 196762
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20358, 20359, 20360, 20361
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100400682, 100400707, 100413489, 100413495
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65647001, W65648001
Country: SG	Health Sciences Authority	Identifier(s): 15757P, 15758P, 15759P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636091463, 8699636091470, 8699636261446, 8699636261453
Country: US	FDA, National Drug Code	Identifier(s): 0006-3075, 0006-3076, 0006-5003, 0006-5004